Buscar resultados de ensayos clínicos
Oculodentodigital Dysplasia - 11 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients Condición: Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients Fecha: 2009-08-18 Intervenciones:
|
Completed |
Nombre del estudio: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients Condición: Basal Cell Nevus Syndrome Fecha: 2016-04-27 Intervenciones:
|
Completed |
Nombre del estudio: To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) Condición:
Fecha: 2009-08-05 Intervenciones: Drug: GDC-0449 capsule, 150 mg, one pill daily, 18 months |
Completed |
Nombre del estudio: Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas Condición:
Fecha: 2012-03-14 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) Condición:
|
Terminated |
Nombre del estudio: Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. Condición:
|
Active, not recruiting |
Nombre del estudio: Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome Condición: Basal Cell Nevus Syndrome Fecha: 2014-06-02 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms Condición: Musculoskeletal Complications Fecha: 2013-07-02 Intervenciones:
|
Completed |
Nombre del estudio: A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions Condición: Basal Cell Carcinoma Fecha: 2009-11-16 |
Recruiting |
Nombre del estudio: Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the Size of Sporadic Nodular Basal Cell Carcinomas Condición: Basal Cell Carcinomas Fecha: 2016-07-01 Intervenciones:
|